title: Botulinum neurotoxin A decreases infiltrating cutaneous lymphocytes and improves acanthosis in the KC-Tie2 mouse model.
authors.forename: Nicole L
authors.initials: NL
authors.lastname: Ward
authors.forename: Kevin D
authors.initials: KD
authors.lastname: Kavlick
authors.forename: Doina
authors.initials: D
authors.lastname: Diaconu
authors.forename: Sean M
authors.initials: SM
authors.lastname: Dawes
authors.forename: Kellie A
authors.initials: KA
authors.lastname: Michaels
authors.forename: Erin
authors.initials: E
authors.lastname: Gilbert
mesh_terms: D000052:Acanthosis Nigricans / Q000188:drug therapy*; D000818:Animals; D019274:Botulinum Toxins, Type A / Q000494:pharmacology / Q000627:therapeutic use*; D039521:CD11c Antigen / Q000032:analysis; D015740:Calcitonin Gene-Related Peptide / Q000502:physiology; D008214:Lymphocytes / Q000187:drug effects* / Q000502:physiology; D051379:Mice; D011565:Psoriasis / Q000188:drug therapy; D012867:Skin / Q000187:drug effects* / Q000473:pathology; D013373:Substance P / Q000502:physiology
chemical_list: D039521:CD11c Antigen; D013373:Substance P; D019274:Botulinum Toxins, Type A; D015740:Calcitonin Gene-Related Peptide